Interleukin-13 and interleukin-4 are coexpressed in atopic asthma

scientific article published on 01 September 1996

Interleukin-13 and interleukin-4 are coexpressed in atopic asthma is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID8902881

P2093author name stringErnst P
Hamid QA
Kotsimbos TC
P433issue5
P921main subjectasthmaQ35869
allergic asthmaQ12301086
P304page(s)368-373
P577publication date1996-09-01
P1433published inProceedings of the Association of American PhysiciansQ7247175
P1476titleInterleukin-13 and interleukin-4 are coexpressed in atopic asthma
P478volume108

Reverse relations

cites work (P2860)
Q39793259Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway
Q35642196Analysis of a Panel of 48 Cytokines in BAL Fluids Specifically Identifies IL-8 Levels as the Only Cytokine that Distinguishes Controlled Asthma from Uncontrolled Asthma, and Correlates Inversely with FEV1
Q91964998Application of structured statistical analyses to identify a biomarker predictive of enhanced tralokinumab efficacy in phase III clinical trials for severe, uncontrolled asthma
Q52776417Development and analytical performance of a new ARCHITECT automated dipeptidyl peptidase-4 immunoassay.
Q38248590Dupilumab: a novel treatment for asthma
Q38390424Eosinophils in mucosal immune responses
Q42244544Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
Q35232971Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness
Q24815017Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation
Q36736317Heparin and structurally related polymers attenuate eotaxin-1 (CCL11) release from human airway smooth muscle.
Q35964168Identification of an interleukin 13-induced epigenetic signature in allergic airway inflammation.
Q34003580Importance of cytokines in murine allergic airway disease and human asthma
Q42101278Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).
Q33900766Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts
Q35010562Interleukin-13: prospects for new treatments
Q33731233Modulation of exaggerated-IgE allergic responses by gene transfer-mediated antagonism of IL-13 and IL-17e
Q36597355Mucin overproduction in chronic inflammatory lung disease
Q51638531Mushroom plant workers experience a shift towards a T helper type 2 dominant state: contribution of innate immunity to spore antigen.
Q47151392NKT cells contribute to basal IL-4 production but are not required to induce experimental asthma.
Q35070524NKT cells in the induced sputum of severe asthmatics
Q39735936Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling
Q24652737Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge
Q24620510Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma
Q40849898Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
Q34567533Regulation of allergic airways inflammation by cytokines and glucocorticoids
Q36438370Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice
Q37807414Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.
Q35102219Selective stimulation of IL-4 receptor on smooth muscle induces airway hyperresponsiveness in mice
Q35685186T cell directives for transcriptional regulation in asthma
Q33753434Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation
Q35103250Transforming growth factor-beta2 induces bronchial epithelial mucin expression in asthma.

Search more.